Home | Business News | CBJ Newsmakers | As Deadline Approaches, Knight Therapeutics Reminds Shareholders to Vote the BLUE Proxy for Nominees Who Support Jonathan Goodman’s Vision As Deadline Approaches, Knight Therapeutics Reminds Shareholders to Vote the BLUE Proxy for Nominees Who Support Jonathan Goodman’s Vision CBJ Newsmakers RecommendedGolden Tag Completes $7.0 Million Oversubscribed Non-Brokered Private Placement Led by Eric Sprott and Announces Director AppointmentShaw Gigabit Download Speeds Now Accessible to All Shaw Residential Internet Customers Across AlbertaGuardian Capital Group acquires majority interest in independent US asset manager Agincourt Capital Management LLC
